CAR-T cell therapy specialists in Singapore

Chin Tan Min

Cancer · Singapore

Dr Chin Tan Min is a medical oncologist at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. Her areas of expertise lie in lung cancers and general oncology. She was awarded the Health Manpower Development Programme (HMDP) fellowship to pursue further subspecialisation training in thoracic oncology, with a clinical and research fellowship at the Massachusetts General Hospital Cancer Centre in the US. Prior to private practice, she was a senior consultant at the National University Cancer Institute at NUH, and a visiting consultant at Ng Teng Fong Hospital. Dr Chin contributes her expertise in thoracic oncology in various Ministry of Health committees, formulating guidelines on screening and treatment for lung cancers. She is also an advisory member for lung cancer for Singapore Cancer Society, and has been involved in educational talks for the public. She was also core faculty for the oncology senior residency programme at National University Health System. She is the principal associate at the Cancer Science Institute of Singapore, where she continues her current research. She is a member of American Society of Clinical Oncology, American Association for Cancer Research, and the International Association of Lung Cancer. With a keen and active interest in translational and clinical research to better patient care, she has conducted several international industry-sponsored and investigator-initiated clinical trials as principal and co-investigator. Dr Chin’s work has been published in peer-reviewed, high-impact factor journals such as Nature, Nature Medicine and Journal of Clinical Oncology. She contributed to the development of EGFR mutation detection test/kit in lung cancers, in both tumour and blood. Her commitment to patient care has been recognised by SPRING’s Excellent Service Award.

Chin Tan Min

Cancer · Singapore

Dr Chin Tan Min is a medical oncologist at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. Her areas of expertise lie in lung cancers and general oncology. She was awarded the Health Manpower Development Programme (HMDP) fellowship to pursue further subspecialisation training in thoracic oncology, with a clinical and research fellowship at the Massachusetts General Hospital Cancer Centre in the US. Prior to private practice, she was a senior consultant at the National University Cancer Institute at NUH, and a visiting consultant at Ng Teng Fong Hospital. Dr Chin contributes her expertise in thoracic oncology in various Ministry of Health committees, formulating guidelines on screening and treatment for lung cancers. She is also an advisory member for lung cancer for Singapore Cancer Society, and has been involved in educational talks for the public. She was also core faculty for the oncology senior residency programme at National University Health System. She is the principal associate at the Cancer Science Institute of Singapore, where she continues her current research. She is a member of American Society of Clinical Oncology, American Association for Cancer Research, and the International Association of Lung Cancer. With a keen and active interest in translational and clinical research to better patient care, she has conducted several international industry-sponsored and investigator-initiated clinical trials as principal and co-investigator. Dr Chin’s work has been published in peer-reviewed, high-impact factor journals such as Nature, Nature Medicine and Journal of Clinical Oncology. She contributed to the development of EGFR mutation detection test/kit in lung cancers, in both tumour and blood. Her commitment to patient care has been recognised by SPRING’s Excellent Service Award.

Chin Tan Min

Cancer · Singapore

Dr Chin Tan Min is a medical oncologist at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. Her areas of expertise lie in lung cancers and general oncology. She was awarded the Health Manpower Development Programme (HMDP) fellowship to pursue further subspecialisation training in thoracic oncology, with a clinical and research fellowship at the Massachusetts General Hospital Cancer Centre in the US. Prior to private practice, she was a senior consultant at the National University Cancer Institute at NUH, and a visiting consultant at Ng Teng Fong Hospital. Dr Chin contributes her expertise in thoracic oncology in various Ministry of Health committees, formulating guidelines on screening and treatment for lung cancers. She is also an advisory member for lung cancer for Singapore Cancer Society, and has been involved in educational talks for the public. She was also core faculty for the oncology senior residency programme at National University Health System. She is the principal associate at the Cancer Science Institute of Singapore, where she continues her current research. She is a member of American Society of Clinical Oncology, American Association for Cancer Research, and the International Association of Lung Cancer. With a keen and active interest in translational and clinical research to better patient care, she has conducted several international industry-sponsored and investigator-initiated clinical trials as principal and co-investigator. Dr Chin’s work has been published in peer-reviewed, high-impact factor journals such as Nature, Nature Medicine and Journal of Clinical Oncology. She contributed to the development of EGFR mutation detection test/kit in lung cancers, in both tumour and blood. Her commitment to patient care has been recognised by SPRING’s Excellent Service Award.

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Dr. Choo Bok Ai 朱博爱医生

20+ years of experience · Cancer · Singapore

Senior Radiation Oncologist specializing in breast, gynecological, head & neck, skin and sarcoma cancers with expertise in advanced radiotherapy techniques.

Dr. Choo Su Pin 朱舒嫔医生MRCP (UK)

20+ years of experience · Cancer · Singapore

Senior Medical Oncologist specializing in gastrointestinal cancers with 20+ years of experience in GI oncology, clinical trials, and immuno-oncology research.

Dr. Daniel Tan Yat Harn 陈约翰医生

20+ years of experience · Cancer · Singapore

Radiation oncologist specializing in stereotactic radiosurgery (SRS/SBRT), brain & spine tumors, breast and prostate cancers with advanced radiation expertise.

Dr. David Tan Boon Harn 陈文翰医生FRCR

15+ years of experience · Cancer · Singapore

Radiation oncologist specializing in gynecological, gastrointestinal, lung and hepatobiliary cancers, with expertise in SBRT, SRS and brachytherapy.

Dr. Hsieh Wen-Son 謝文荪医生

Cancer · Singapore

Dr. Hsieh Wen-Son is a Medical Oncologist specialising in the treatment of a wide range of cancers, with particular expertise in head and neck cancers, lung cancers, hepatobiliary malignancies, and lymphoma. He is actively involved in advancing cancer care through molecularly targeted therapies, immunotherapy, and molecular diagnostics. Dr. Hsieh has led multiple international multi-centre clinical studies across Singapore, Hong Kong, Korea, the Philippines, and the United States, focusing on novel diagnostics and treatments for nasopharyngeal carcinoma and hepatocellular carcinoma. He currently serves as Principal Investigator for more than ten ongoing clinical trials aimed at developing more effective cancer therapies with reduced side effects. He has authored over 70 scientific publications, including journal articles, abstracts, and book chapters, and is a frequent speaker at regional and international scientific conferences. Dr. Hsieh holds academic appointments as a part-time Assistant Professor at Johns Hopkins University and serves as a Principal Associate at the Cancer Sciences Institute of Singapore, National University of Singapore. He studied Philosophy and Psychology at the University of Oxford under the Rhodes Scholarship and completed his medical training at Johns Hopkins University and Duke University. Following his training, he served as a full-time faculty member at Johns Hopkins University School of Medicine, contributing to patient care, teaching, and research.

Dr. Imran Nawaz

40+ years of experience · Cancer · Singapore

Dr. Imran Nawaz is a Senior Consultant General Surgeon with extensive experience in both routine and complex surgical care, including minimally invasive procedures and surgical oncology. He graduated from the National University of Singapore with a degree in Medicine and Surgery in 1982 and began his surgical training at Singapore General Hospital, rotating through general surgery, orthopedics, and cardiothoracic surgery. After completing basic surgical training, he was admitted as a Fellow of the Royal College of Surgeons of Edinburgh and the Royal College of Surgeons of Glasgow in 1987. He subsequently served at Tan Tock Seng Hospital, progressing from Registrar to Senior Registrar and Consultant Surgeon, and also contributed to medical education as a Clinical Tutor at NUS. In 1990, he was awarded the Singapore Government Higher Manpower Development Scholarship in General and Vascular Surgery, completing advanced fellowship training at the University of New South Wales in Sydney. In 1995, he entered private practice as a Senior Consultant in General Surgery. His clinical expertise includes general surgical procedures such as hernia repair, hemorrhoid treatment, appendectomies, and gallstone surgery, as well as minimally invasive surgery and cancer surgery involving the colon, rectum, stomach, thyroid, and breast. He has also contributed to trauma training as Course Director of the Advanced Trauma Life Support (ATLS) programme and has served in senior leadership roles within the Singapore Armed Forces Medical Services.